PhaseRx Lands $19,000,000 Series A Financing Round

  • Feed Type
  • Date
    2/28/2008
  • Company Name
    PhaseRx
  • Mailing Address
    Undisclosed Seattle, WA 98104
  • Company Description
    The company is developing therapies via sIRNA technologies.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $19,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    The first tranche of $4 million will be used for initial research milestones.
  • M&A Terms
  • Venture Investor
    5AM Ventures
  • Venture Investor
    ARCH Venture Partners
  • Venture Investor
    Versant Ventures

By posting a comment, you agree to our terms and conditions.